Orange County NC Website
<br /> <br />33 <br />Revised 9/8/2021 <br /> as determined through reference to public prices or other reasonable measur es of fair <br /> market value, and does not represent more than a 5% ownership interest in any single <br /> entity; or <br /> e. salary, royalties or other payments that, when aggregated for the PI/P D and the <br /> investigator’s spouse and dependent children, are not expected to exceed $10,000 <br /> during the prior twelve -month period. <br />The term “or other interest” means a non-financial benefit which results in a potential or real <br />conflict of interest. The potential or real conflict of interest poses the same possible harms <br />received from a financial conflict of interest such as bias due to personal gain. Such benefits <br />may be received from a tangible or intangible personal benefit. <br /> “Organizational conflicts of interest” means that because of relations hips with a parent <br />company, affiliate, or subsidiary organization, the non-Federal entity is unable or appears to be <br />unable to be impartial in conducting a procurement action involving a related or ganization. <br />“Responsible representative” means the individual(s), named by the applicant/recipient <br />organization, who is authorized to act on behalf of the applicant/recipient and to assume <br />responsibility for the obligations imposed by federal laws, regulations, re quirements, and <br />conditions that apply to CMS grant awards. <br />Requirements: <br />The majority of CMS’ grant programs are not supported by Public Health Service (PHS) <br />funding; therefore, CMS is not subject to the requirements of 42 CFR P art 50, Subpart F, <br />“Promoting Objectivity in Research.” Notwithstanding, CMS expects grant activities (including <br />research activities) to be free from bias by any conflicting interest of the PI/PD and any other <br />person regardless of title or position, who is responsible for the design, conduct, or reporting of <br />grant activities which may include collaborators or consultants. <br />Recipient’s conflict of interest policies must reflect the following: <br />• Have a written and enforced administrative process to eliminate conflicting financial <br />or other interests with respect to CMS grant/cooperative agreement funds a warded. <br />This process should ensure: <br /> The merits for determining a conflict of interest are clearly articulated in writing – <br />i.e., the assigned reviewer(s) can reasonably determine that a significant or other <br />interest could directly and significantly affect the design, conduct, or re porting of <br />CMS-funded grant activities. This process should be inclusive of the appearance <br />of such conflicts. <br /> Each PI/PD discloses to a responsible representative of the Recipient all <br />significant financial and/or other interests including personal relationships of the <br />PI/PD (for example, PI/PD’s spouse, dependent children, etc.): (i) that would <br />reasonably appear to be affected by the grant activities funded or proposed for <br />DocuSign Envelope ID: 7832B0E4-F34E-430E-A3C2-1A6A14F29307